Branchburg, February
22, 2013, ---Hydromer, Inc. (HYDI.PK)
announced that during last 30 days it entered into License Agreements with two non-USA
based medical device manufacturers.

In January
2013, an Agreement was entered with a Chinese Medical Device company licensing
the use of a proprietary Hydromer® medical coating for use on
Nelaton Urinary Self-Catheters.The
Chinese Medical Device company intends to manufacture the catheters in China
and sell the coated product globally.

In early February
2013, an Agreement was entered with a United Arab Emirates based Medical Device
company licensing the use of two proprietary Hydromer® medical
coatings for use on PTCA/PTA Catheters.This UAE based Medical Device company intends to market their precision
vascular access catheters in the Middle East and Global markets.

“Our focus in
the lucrative and rapidly growing Chinese Medical Device market is gaining
momentum as more Chinese companies are evaluating our coatings which have
previous approvals with international regulatory agencies such as the US FDA,
SFDA, CE/ISO, Japanese and others.”, commented Martin von Dyck, Executive Vice
President of Hydromer, Inc., adding, “We are quite proud with our new UAE
relationship, who selected Hydromer coatings based on our superior performance,
previous regulatory approvals and high certainty of preventing particulate
contamination in the blood stream.Hydromer coatings continually pass the USP 788 Particulate Matter in
Injections test and the challenging Japanese
Ministry of Health’s Eluate
test as well as the stringent ISO 8536-4 and China’s GB/T14233.1 tests for
reducing oxidizable matter.Passing all of these required tests ensures
that Hydromer medical coatings continue to be prized globally as a premium biocompatible
value added product.”